SeaStar Medical director granted 4,000 RSUs

Baird Jennifer A reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/02/2026 - 05:04 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Baird Jennifer A reported acquisition or exercise transactions in this Form 4 filing.

SeaStar Medical Holding Corp director Jennifer A. Baird received an equity grant of 4,000 shares in the form of restricted stock units. These RSUs relate to common stock with a par value of $0.0001 per share and will vest in full on July 1, 2027.

After this award, Baird holds a total of 10,620 shares of SeaStar Medical common stock directly, reflecting her updated ownership position as reported in this Form 4 filing.

Insider Trade Summary

Grant/Award: 4,000 shares

Grant/Award 1 txn

Insider Baird Jennifer A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.0001	4,000	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.0001 — 10,620 shares (Direct)

Footnotes (1)

1. F1. Represent a restricted stock unit award ("RSU"). The RSUs will vest in full on July 1, 2027.

Key Figures

RSU grant size: 4,000 RSUs Vesting date: July 1, 2027 Total shares after transaction: 10,620 shares +1 more

4 metrics

RSU grant size 4,000 RSUs Restricted stock unit award to director Jennifer A. Baird

Vesting date July 1, 2027 RSUs vest in full on this date

Total shares after transaction 10,620 shares Direct holdings of SeaStar Medical common stock after award

Security type Common Stock, par value $0.0001 Underlying security for the RSU award

Key Terms

restricted stock unit award ("RSU"), Common Stock, par value $0.0001, grant, award, or other acquisition

3 terms

restricted stock unit award ("RSU") financial

"Represent a restricted stock unit award ("RSU"). The RSUs will vest in full on July 1, 2027."

Common Stock, par value $0.0001 financial

"security_title: "Common Stock, par value $0.0001""

grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SeaStar Medical (ICU) report for Jennifer A. Baird?

SeaStar Medical reported that director Jennifer A. Baird received an award of 4,000 restricted stock units. These RSUs represent shares of common stock and were granted as a non-cash equity award, updating her disclosed ownership position in the company.

How many SeaStar Medical (ICU) shares does Jennifer A. Baird hold after this Form 4?

Following the reported transaction, Jennifer A. Baird holds 10,620 shares of SeaStar Medical common stock directly. This total includes the newly granted 4,000 restricted stock units, which contribute to her overall disclosed equity stake in the company.

When do Jennifer A. Baird’s SeaStar Medical (ICU) RSUs vest?

The 4,000 restricted stock units granted to Jennifer A. Baird vest in full on July 1, 2027. Vesting means the award becomes fully earned on that date, subject to the terms and conditions of the underlying equity agreement.

What type of security was granted to SeaStar Medical (ICU) director Jennifer A. Baird?

Jennifer A. Baird received a restricted stock unit award tied to SeaStar Medical’s common stock, par value $0.0001 per share. RSUs are equity awards that convert into shares of common stock upon vesting under specified conditions.

Was Jennifer A. Baird’s SeaStar Medical (ICU) award a purchase or a grant?

The transaction was a grant or award acquisition, not an open-market purchase. The Form 4 classifies it under code A, indicating a grant, award, or other acquisition of 4,000 restricted stock units for director Jennifer A. Baird.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baird Jennifer A

(Last) (First) (Middle)

3513 BRIGHTON BLVD

SUITE 410

(Street)

DENVER COLORADO 80216

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SeaStar Medical Holding Corp [ ICU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001	07/01/2026		A		4,000(1)	A	$0	10,620	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represent a restricted stock unit award ("RSU"). The RSUs will vest in full on July 1, 2027.

	/s/ Eric Schlorff as-attorney-in-fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)